Drugs & Medicine Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 421 results
Pharmaceutical
FDA DrugsClass II

Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: A...

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

May 13, 2026Ajanta Pharma Ltd.
Pharmaceutical
FDA DrugsClass II

BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alc...

Lack of assurance of Sterility: potential product contamination

May 13, 2026CareFusion 213, LLC
Pharmaceutical
FDA DrugsClass II

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single ...

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

May 6, 2026Hikma Pharmaceuticals USA INC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 ...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mc...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in...

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

May 6, 2026Thea Pharma, Inc.
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Systane, Lubricant Eye Gel, Night Gel, Sterile, 10g (0.35 oz), Processed in Fran...

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

May 6, 2026Alcon Research LLC
Pharmaceutical
FDA DrugsClass III

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2...

Failed PH Specifications

May 6, 2026Water-Jel Technologies, LLC
Pharmaceutical
FDA DrugsClass III

Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For i...

Labeling: Missing Label

May 6, 2026American Regent, Inc.
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per m...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma ...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 m...

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

May 6, 2026Thea Pharma, Inc.
Pharmaceutical
FDA DrugsClass II

GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alc...

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

May 6, 2026Alcon Research LLC
Pharmaceutical
FDA DrugsClass II

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, M...

Lack of Assurance of Sterility

May 6, 2026SCOPE HEALTH
Pharmaceutical
FDA DrugsClass II

LACTATED RINGER'S IRRIGATION, 3000 mL bags, Sterile, Ex only, B. Braun Medical I...

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Apr 29, 2026B BRAUN MEDICAL INC
Pharmaceutical
FDA DrugsClass III

Premier, Monsel's, Ferric Subsulfate Solution, 8 mL bottles, Rx only, Manufactur...

Labeling: Incorrect or Missing Lot and/or Exp Date:The expiration date has an extra digit and is printed as 2709114 instead of the correct 270914 (2027-09-14). It is important to note that this error is limited to the vial itself; the saleable unit of the box of 12 bottles has the correct expiration date printed.

Apr 29, 2026Premier Dental Products Co
Pharmaceutical
FDA DrugsClass II

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: L...

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Apr 29, 2026Leading Pharma, LLC
Pharmaceutical
FDA DrugsClass II

Sterile Water for Injection USP, 3000 mL bags, Rx only, Pharmacy Bulk Package, B...

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Apr 29, 2026B BRAUN MEDICAL INC
Pharmaceutical
FDA DrugsClass II

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical In...

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Apr 29, 2026B BRAUN MEDICAL INC
Pharmaceutical
FDA DrugsClass II

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx ...

Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

Apr 29, 2026Hetero Labs Limited (Unit V)
Pharmaceutical
FDA DrugsClass II

Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, ND...

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Apr 29, 2026Teva Pharmaceuticals USA, Inc